SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:lup.lub.lu.se:ba14edba-4d94-410f-9e9e-173b433f974d"
 

Search: onr:"swepub:oai:lup.lub.lu.se:ba14edba-4d94-410f-9e9e-173b433f974d" > Effect of high-dose...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Effect of high-dose vitamin A supplementation on the immune response to Bacille Calmette-Guerin vaccines

Diness, Birgitte R. (author)
Fisker, Ane B. (author)
Roth, Adam (author)
Lund University,Lunds universitet,Klinisk mikrobiologi, Malmö,Forskargrupper vid Lunds universitet,Clinical Microbiology, Malmö,Lund University Research Groups
show more...
Yazdanbakhsh, Maria (author)
Sartono, Erliyani (author)
Whittle, Hilton (author)
Nante, Jose E. (author)
Lisse, Ida M. (author)
Ravn, Henrik (author)
Rodrigues, Amabelia (author)
Aaby, Peter (author)
Benn, Christine S. (author)
show less...
 (creator_code:org_t)
2007
2007
English.
In: American Journal of Clinical Nutrition. - 1938-3207. ; 86:4, s. 1152-1159
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Background: Vitamin A supplementation (VAS) at birth has been associated with decreased mortality in Asia. Bacille Calmette-Guerin (BCG) vaccine is given at birth in tuberculosis-endemic countries. Previous studies suggest that VAS may influence the immune response to vaccines. Objective: Our objective was to examine whether VAS influences the immune response to simultaneously administered BCG vaccine. Design: Within a randomized trial of 50 000 IU vitamin A or placebo Given with BCG vaccine at birth in Guinea-Bissau, 27 10 infants were examined for BCG scar formation and delayed-type hypersensitivity (DTH) to purified protein derivative of Mycobacterium tuberculosis (PPD) at 2 and 6 mo of age. The ex vivo cytokine response to PPD was measured in 607 infants. Results: At 2 mo of age, 39% (43% of the boys and 34% of the girls) responded to PPD. The prevalence ratio of a measurable PPD reaction for VAS compared with placebo recipients was 0.90 (95% CI: 0.80, 1.02) for all infants. 0.81 (95% CI: 0.69, 0.95) for boys, and 1.04 (95% CI: 0.86, 1.26) for girls. At 6 mo of age, 42% of the infants responded to PPD. No difference was observed between VAS and placebo recipients. The prevalence of BCG scar was not affected by VAS. The ex vivo interferon-gamma response to PPD was increased by VAS (means ratio: 1.40: 95% CI: 1.03, 1.91). Conclusions: VAS with BCG vaccination does not appear to interfere with the long-term immune response to BCG. However, VAS temporarily altered the DTH reaction to PPD in boys at 2 mo of age, suggesting sex differences in the immunologic response to VAS Given with BCG. This trial was registered at www.clinicaltrials.gov as #NCT00168597.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Hälsovetenskap -- Näringslära (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Health Sciences -- Nutrition and Dietetics (hsv//eng)

Keyword

BCG vaccination
Bacille Calmette-Guerin
vitamin A
purified protein derivative of Mycobacterium tuberculosis response
PPD response
sex-differential effects
randomized trial

Publication and Content Type

art (subject category)
ref (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view